4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001209191-23-046150
Chief Executive Officer bought 444,444 shares at $0.90 ($400,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nolan Sean P. Chief Executive Officer | 2023-08-16 | Purchase | +444,444 | $0.90 | $400,000 | 1,535,545 | I |
| Open-market purchases · 444,444 sh · avg $0.90 · $400,000 | |||||||
Loading xslF345X05/doc4.xml…